Seoul, South Korea

Hyung Eun Lee

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 8.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hyung Eun Lee: Innovator in Neuropsychiatric Pharmaceutical Compositions

Introduction

Hyung Eun Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of neuropsychiatric diseases. With a total of two patents to his name, Lee's work focuses on innovative compositions that aim to improve cognitive function and address various cognitive disorders.

Latest Patents

Hyung Eun Lee's latest patents include a pharmaceutical composition for treating or preventing neuropsychiatric diseases, which contains flavone-6-C-glucose derivatives as active ingredients. This invention provides a composition that effectively treats or prevents cognitive dysfunction disorders such as delirium, dementia, amnesia, stroke, and anxiety disorders. Another notable patent is a pharmaceutical composition for the prevention or treatment of cognitive function disorders comprising spinosin. This composition is designed to improve memory and learning ability while effectively treating cognitive function disorders like dementia and amnesia.

Career Highlights

Throughout his career, Hyung Eun Lee has worked with notable organizations, including Dae Hwa Pharma Co., Ltd. and the Ministry of Food and Drug Safety. His experience in these institutions has allowed him to develop and refine his innovative pharmaceutical compositions.

Collaborations

Hyung Eun Lee has collaborated with esteemed colleagues such as Jong Hoon Ryu and Jae Hoon Cheong. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.

Conclusion

Hyung Eun Lee is a dedicated inventor whose work in neuropsychiatric pharmaceutical compositions has the potential to significantly impact the treatment of cognitive disorders. His innovative approaches and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…